Stephen Mayo - 08 Jul 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
Veer Bhavnagri as attorney-in-fact
Issuer symbol
ALLO
Transactions as of
08 Jul 2022
Net transactions value
$0
Form type
4
Filing time
12 Jul 2022, 16:48:48 UTC
Previous filing
01 Jun 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +35,328 $0.000000 35,328 08 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +54,487 $0.000000 54,487 08 Jul 2022 Common Stock 54,487 $12.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The shares subject to the stock option shall vest in a series of 36 successive equal installments measured from the date of grant.